Renn Fund Inc  

(Public, NYSEMKT:RCG)   Watch this stock  
Find more results for NYSEAMEX:RCG
1.34
+0.03 (2.29%)
Dec 19 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 1.31 - 1.36
52 week 1.01 - 1.72
Open 1.33
Vol / Avg. 3,101.00/14,476.00
Mkt cap 5.98M
P/E     -
Div/yield     -
EPS -0.41
Shares 4.46M
Beta 0.53
Inst. own 9%

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 279080.00% -1698.52%
Operating margin -307510.00% -1398.10%
EBITD margin - -1398.10%
Return on average assets 5.18% -6.18%
Return on average equity 5.21% -6.73%
CDP Score - -

Address

8080 N Central Expy Ste 210lb59
DALLAS, TX 75206-1838
United States - Map
+1-214-8918294 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

NOVT Corporation, the United States based company, does not have significant operations. The company intends to redeploy its existing resources to identify and acquire new business operations. Previously it operated as a medical device company that was engaged in developing therapeutic solutions for the prevention and treatment of vascular disease. In 2006, the company completed the sale of its vascular brachytherapy (VBT) business, which is the Company's only business line, to Best Vascular, Inc. NOVT's redeployment strategy will involve the acquisition of one or more operating businesses with existing or prospective taxable earnings. This strategy may allow NOVT to realize future cash flow benefits from its net operating loss carry-forwards ("NOLs")

Officers and directors

Russell C Cleveland Chairman of the Board, President, Chief Executive Officer
Age: 74
Bio & Compensation  - Reuters
Kevin W. McAleer Chief Financial Officer, Treasurer, Acting Corporate Secretary
Age: 62
Bio & Compensation  - Reuters
Scott E. Douglass Vice President
Age: 54
Bio & Compensation  - Reuters
Z. Eric Stephens Vice President
Age: 45
Bio & Compensation  - Reuters
Ernest C. Hill Independent Director
Age: 73
Bio & Compensation  - Reuters
J. Philip P. McCormick Independent Director
Age: 72
Bio & Compensation  - Reuters
Charles C. Pierce Jr. Independent Director
Age: 78
Bio & Compensation  - Reuters